Search research articles
Contact Us
Filters
Showing results (111-120 of 120) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 120 results.
Tumori
|
June 12, 2020
Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S
Maria Di Bartolomeo, Alessandra Raimondi, Fabiola Cecchi, et al.
Journal of Neuroendocrinology
|
November 19, 2025
Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and management
Nicola Fazio, Patrick Maisonneuve, Anna Maria Frezza, et al.
The Oncologist
|
May 10, 2015
Real-world study of everolimus in advanced progressive neuroendocrine tumors
Francesco Panzuto, Maria Rinzivillo, Nicola Fazio, et al.
The Oncologist
|
August 14, 2014
Real-world study of everolimus in advanced progressive neuroendocrine tumors
Francesco Panzuto, Maria Rinzivillo, Nicola Fazio, et al.
Endocrine-Related Cancer
|
March 17, 2023
COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study
Nicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
Endocrine-Related Cancer
|
March 22, 2018
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors
Sara Pusceddu, Francesco Barretta, Annalisa Trama, et al.
Endocrine
|
January 4, 2024
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database
Francesco Panzuto, Stefano Partelli, Davide Campana, et al.
Gastroenterology
|
April 16, 2018
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues
Sara Pusceddu, Claudio Vernieri, Massimo Di Maio, et al.
JAMA Network Open
|
February 24, 2022
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
Sara Pusceddu, Natalie Prinzi, Salvatore Tafuto, et al.
Science Advances
|
March 6, 2018
Einstein@Home discovers a radio-quiet gamma-ray millisecond pulsar
Colin J Clark, Holger J Pletsch, Jason Wu, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 120) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 120 results.
Tumori
|
June 12, 2020
Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S
Maria Di Bartolomeo, Alessandra Raimondi, Fabiola Cecchi, et al.
Journal of Neuroendocrinology
|
November 19, 2025
Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and management
Nicola Fazio, Patrick Maisonneuve, Anna Maria Frezza, et al.
The Oncologist
|
May 10, 2015
Real-world study of everolimus in advanced progressive neuroendocrine tumors
Francesco Panzuto, Maria Rinzivillo, Nicola Fazio, et al.
The Oncologist
|
August 14, 2014
Real-world study of everolimus in advanced progressive neuroendocrine tumors
Francesco Panzuto, Maria Rinzivillo, Nicola Fazio, et al.
Endocrine-Related Cancer
|
March 17, 2023
COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study
Nicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
Endocrine-Related Cancer
|
March 22, 2018
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors
Sara Pusceddu, Francesco Barretta, Annalisa Trama, et al.
Endocrine
|
January 4, 2024
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database
Francesco Panzuto, Stefano Partelli, Davide Campana, et al.
Gastroenterology
|
April 16, 2018
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues
Sara Pusceddu, Claudio Vernieri, Massimo Di Maio, et al.
JAMA Network Open
|
February 24, 2022
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
Sara Pusceddu, Natalie Prinzi, Salvatore Tafuto, et al.
Science Advances
|
March 6, 2018
Einstein@Home discovers a radio-quiet gamma-ray millisecond pulsar
Colin J Clark, Holger J Pletsch, Jason Wu, et al.
Page
of 12